Compliance Certificate under Reg 74(5) of SEBI (DP) Regulations, 2018
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eiko Lifesciences has submitted a compliance certificate from its Registrar and Share Transfer Agent, Bigshare Services Pvt. Ltd., for the quarter ended 31st March 2025. The certificate confirms that no dematerialisation requests for equity shares of the company were received between 1st January 2025 and 31st March 2025. The filing was made by Chintan Doshi, the Company's Secretary and Compliance Officer. This is a routine regulatory submission required under SEBI's Depository Regulations.
This is a standard procedural compliance filing with no material impact on the company's operations or stock price. It simply confirms routine activity (or lack thereof) regarding share dematerialisation during the quarter.